The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Long-Term side Effects of Newer-Generation Antidepressants: SSRIS, Venlafaxine, Nefazodone, Bupropion, and Mirtazapine
Abstract
Anecdotal reports have suggested that the long-term use of selective serotonin reuptake inhibitors (SSRIs) may be associated with significant weight gain, sexual dysfunction, drug interactions, and discontinuation symptoms. Are these effects inevitable or can they be managed effectively with the appropriate interventions? In reviewing published, controlled clinical trials, it has been noted that many depressed patients experience weight gain during remission with or without treatment. Most antidepressants appear to produce a 3- to 4-kg weight gain after 6-12 months of therapy, which may be managed with nutritional counseling and exercise. The exception is mirtazapine, which appears to be associated with significant weight gain early in therapy. Antidepressant-induced sexual dysfunction is also common but may be managed with the addition of an antidote or substitution. Drug interactions are most common with fluvoxamine, nefazodone, and fluoxetine because these agents are more likely to affect the metabolism of commonly prescribed medications. It may be possible to prevent discontinuation symptoms with a cross taper to another antidepressant or by slowly tapering the antidepressant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although widely used and efficacious [8–10], SRI use long-term is associated with adverse side effects [11–14]”
From Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods (2018) · cites this paper as [11]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Bauer, M., Bschor, T., Pfennig, A., Whybrow, P. C., Angst, J., Versiani, M., Möller, H.-J., WFSBP Task Force on Unipolar Depres, Bauer, M., Bschor, T., et al. (2007) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701227829 · Cited by 477
“The ‘‘newer’’ antide- pressants are associated with fewer long-term side effects than are the older tricyclics and tetracyclics (AHCPR 1993, 1999; American Psychiatric Asso- ciation 2000; Peretti et al. 2000; Masand and Gupta 2002).”
BackgroundBurden of general medical conditions among individuals with bipolar disorder
Kilbourne, A. M., Cornelius, J. R., Han, X., Pincus, H. A., Shad, M., Salloum, I., Conigliaro, J., & Haas, G. L. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00138.x · Cited by 412
Innovative approaches for the development of antidepressant drugs: Current and future strategies
Schechter, L. E., Ring, R. H., Beyer, C. E., Hughes, Z. A., Khawaja, X., Malberg, J. E., & Rosenzweig-Lipson, S. (2005) · NeuroRX · doi:10.1602/neurorx.2.4.590 · Cited by 228
“In addition, nonselective -2 adrenergic receptors antagonists such as mirtazapine (Remeron) are reported to possess modest antidepressant activity in their own right.(34) Finally, clinical studies emphasize that combining SSRIs with nonselective -2 receptor antagonists actually shortens the time required to achieve an…”
Background
Metadata
- Authors
- Masand, P., & Gupta, S.
- Affiliations
- Duke Medical Center (US)
- ORCID
- Masand, Prakash
- Venue
- Annals of Clinical Psychiatry
- Publisher
- SAGE Publications
- Published
- 2002-09-01
- Volume
- 14
- Issue
- 3
- Pages
- 175-182
- ISSN
- 1040-1237 (ISSN-L)
- OpenAlex
- W4246013491
- Cited by
- 311
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 166 · 2019: 7 · 2018: 11 · 2017: 5 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 16 · 2012: 5
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- antidepressant side effects, selective serotonin reuptake inhibitors, venlafaxine, nefazodone, bupropion, mirtazapine, late effects
- MeSH terms
- Venlafaxine Hydrochloride, Mirtazapine, Cyclohexanols, Drug Interactions, Humans, Mianserin, Piperazines, Sexual Dysfunction, Physiological, Triazoles, Weight Gain, Bupropion, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term side Effects of Newer-Generation Antidepressants: SSRIS, Venlafaxine, Nefazodone, Bupropion, and Mirtazapine. https://app.cochat.ai/papers/10.3109/10401230209147454
- The paper
- Masand, P., & Gupta, S. (2002). Long-Term side Effects of Newer-Generation Antidepressants: SSRIS, Venlafaxine, Nefazodone, Bupropion, and Mirtazapine. Annals of Clinical Psychiatry. https://doi.org/10.3109/10401230209147454
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.